Skip to Main Content

Paper Details

What are the current challenges for machine learning in drug discovery and repurposing?
Expert Opin Drug Discov
12
2022
Author NameAffiliation
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki
Tero AittokallioInstitute for Cancer Research, Oslo University Hospital
Tero AittokallioUniversity of Oslo
  • 1 - 3

Datasets